CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of resuscitation devices and related software solutions, today reported that A. Ernest Whiton, its Chief Financial Officer and Vice President of Administration, is entering into a 10b5-1 sales plan for the sale of shares of ZOLL common stock over an approximate 12-month period. Under the plan, it is anticipated that approximately 60,000 shares will be sold but it is possible that under certain market conditions, the number of shares sold under the Plan may increase to up to 90,000 shares. Sales under the plan are expected to commence in the third quarter of fiscal 2010. The shares to be sold will be acquired upon the exercise of a portion of stock options which were granted to Mr. Whiton over the past eight years. This new plan follows 10b5-1 sales plans entered into by Mr. Whiton in 2006, 2007 and 2008.
